19P Design and evaluation of nanobodies targeting the human tumor protein TCTP

Read full text Summarise with VIRAT
Authors: L.E. Martinez Hernandez, L.C.C. Triana Vidal, B. Calderón Pérez, L. Núñez Muñoz, Roberto Ruíz‐Medrano, Beatriz Xoconostle‐Cázares
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Translationally controlled tumor protein TCTP plays an important role in key oncogenic processes, due to its involvement in anti-apoptotic pathways and its functional antagonism with the pro-apoptotic protein p53. Moreover TCTP is overexpressed in several types of cancer highlighting its relevance as an important therapeutic target. On the other hand, nanobodies derived heavy-chain antibodies represent powerful tools for both diagnostic and therapeutic applications. This aims to design, produce and evaluate nanobodies targeting human TCTP.

Fields of Study & Subjects

Monoclonal and Polyclonal Antibodies Research Toxin Mechanisms and Immunotoxins Protein purification and stability

Publication details

Journal / source
ESMO Open
Volume
11
Pages
106122–106122
Publication date
1 April 2026
Language
EN